Drug information of Dobutamine

Dobutamine

Drug group:

A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.

Mechanism of effect

Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output.

Pharmacodynamic

Dobutamine is a direct-acting inotropic agent whose primary activity results from stimulation of the beta-adrenoceptors of the heart while producing comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects.

Dobutamine acts primarily on beta-1 adrenergic receptors, with little effect on beta-2 or alpha receptors. It does not cause the release of endogenous norepinephrine, as does dopamine.

 Dobutamine is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.

Pharmacokinetics

Absorption

Onset: 1-10 min

Duration: 10 min

Time to peak effect: ~15 min

Distribution

Vd: 0.2 L/kg

Metabolism

Metabolized in tissues and liver by catechol-O-methyl transferase

Metabolites: Glucuronide conjugate, 3-0-methylated dobutamine (inactive)

Elimination

Half-life: 2 min

Clearance: 90 mL/kg/min

Excretion: Urine

Drug indications

Congestive heart failure

Dosage

Usual Adult Dose for Congestive Heart Failure:

Initial dose: 0.5 to 1 mcg/kg/min IV infusion
Maintenance dose: 2 to 20 mcg/kg/min IV infusion
Maximum dose: 40 mcg/kg/min IV infusion

Usual Pediatric Dose for Congestive Heart Failure:

Initial dose: 0.5 to 1 mcg/kg/min IV infusion
Maintenance dose: 2 to 20 mcg/kg/min IV infusion
Maximum dose: 40 mcg/kg/min IV infusion

Alerts

  1. You should not use dobutamine if you are allergic to it.
  2. To make sure dobutamine is safe for you, tell your doctor if you have:
  • high blood pressure;
  • a heart valve disorder; or
  • asthma or sulfite allergy.

Points of recommendation

  • During the administration of dobutamine injection, as with any adrenergic agent,ECG and blood pressure should be continuously monitored. .
  • Hypovolemiashould be corrected with suitable volume expanders before treatment with dobutamine is instituted.
  • Dobutamine, like other ß2- agonists, can produce a mild reduction in serumpotassium concentration, rarely to hypokalemic levels. Accordingly, consideration should be given to monitoring serum potassium.

Pregnancy level

B

Related drugs

Dopamine , Arbutamine


Ask a Pharmacist


User's questions
    No comments yet.